Katalin K.
- Country
- Hungary
- Department
- Ophtalmology
Research Overview
- Evaluation of Efficacy and Safety of Intravitreal EYE103 Versus Ranibizumab in Diabetic Macular Edema: A Randomized, Double-Masked, Multi-Center Study
- Evaluation of Intravitreal BI 764524 in Moderately-Severe to Severe Non-Proliferative Diabetic Retinopathy: A Randomized, Sham-Controlled, Double-Masked Trial
- Evaluation of Suprachoroidal Dexamethasone Acetate (OXU-001) Versus Intravitreal Dexamethasone Implant in Diabetic Macular Edema
Data & Insights
Has run more than one trial at 64 of 92 partner sites.
Specializations
Hepatic Oncology
Specializes in the treatment of hepatocellular carcinoma, with particular focus on combination therapies using transarterial chemoembolization (TACE) alongside innovative therapeutic approaches.
- Advanced liver cancer management
- Interventional oncology techniques
- Targeted therapy combinations
Explores novel treatment strategies for incurable non-metastatic liver cancer patients.
Diabetic Eye Disease
Investigates advanced treatments for diabetic macular edema (DME) and diabetic retinopathy, focusing on innovative drug delivery methods including suprachoroidal administration.
- Retinal disease management
- Novel therapeutic approaches
- Visual acuity preservation
Evaluates cutting-edge interventions for diabetic eye complications using contemporary assessment methods.
Ophthalmology Innovation
Focuses on developing and evaluating new therapeutic agents for retinal disorders, with emphasis on comparative effectiveness against established treatments.
- Anti-VEGF therapy alternatives
- Visual function assessment
- Long-term disease management
Conducts research on optimizing treatment protocols for retinal diseases using standardized evaluation criteria.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.